Medication info
Crestor 2.5 mg (Rosuvastatin Calcium)

Crestor 2.5 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›2.6mg / 1 tablet
Manufacturer / importer
Alinco Pharmaceutical Co., Ltd.
Appearance
White, round film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202600097 · Approved 2026.01.12

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who uses it
Adults
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 2.5 or 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams once daily. Elderly: No dose adjustment is required. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 2.5 or 5 milligrams. Administration of a 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 2.5 or 5 milligrams. Administration of a 40-milligram dose of this medicine is contraindicated in some of these patients.

Ingredients

Manufacturer
Alinco Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
View approved original text

This medication is used for the treatment of primary hypercholesterolemia and familial hypercholesterolemia (including heterozygous form), as well as mixed dyslipidemia. It is effective as an adjunct therapy when diet and exercise alone are inadequate. It helps reduce the risk of cardiovascular disease by improving cholesterol and triglyceride levels. Therefore, this medication plays an important role in maintaining health through the management of blood lipids.

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 2.5 or 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams once daily. Elderly: No dose adjustment is required. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 2.5 or 5 milligrams. Administration of a 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 2.5 or 5 milligrams. Administration of a 40-milligram dose of this medicine is contraindicated in some of these patients.

Precautions

This medication should not be administered to certain patients. For example, it should not be used in patients with an allergy to any ingredient of this medication, severely impaired liver function, muscle disorders, patients taking certain medications concomitantly, patients with severe renal impairment, or women who are pregnant or breastfeeding. This medication may affect liver function; therefore, patients with a history of liver disease or excessive alcohol consumption should have liver function tests conducted before administration and should be monitored periodically. Additionally, if certain conditions such as hypothyroidism or nephrotic syndrome exist, cause-specific treatment should be prioritized. This medication may cause musculoskeletal side effects such as muscle pain or muscle damage; hence, if symptoms such as myalgia, muscle weakness, or cramps occur, a physician should be consulted immediately. Special care is needed for patients with decreased renal function, the elderly, alcoholics, and those with a family history of these conditions. This medication contains lactose; therefore, patients with lactose intolerance should avoid its use. This medication may interact with other drugs; thus, it is essential to inform healthcare providers about any medications currently being taken, as co-administration with certain drugs can increase the blood concentration of this medication, heightening the risk of side effects. Women of childbearing potential should use adequate contraception and should not take this medication during pregnancy or while breastfeeding. If this medication has been taken during pregnancy, it should be discontinued immediately and a healthcare provider should be consulted. There is no specific antidote for overdose, so treatment should be symptomatic, and liver function and muscle enzyme tests should monitor the condition. While taking this medication, dizziness or headache may occur, necessitating caution while driving or operating machinery.

Side effects

Dyspepsia, pruritus, immune thrombocytopenic purpura, facial edema, herpes zoster, vulvar pruritus, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Steven-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, drug-induced morbilliform rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and light, and should be kept at a temperature between 1°C and 30°C. Storing it this way will help maintain its efficacy for a longer period.

Appearance and packaging

Appearance

White, round film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.